Article summary
The Department of Health and Social Care has announced that the government has signed a contract for an additional 114 million Pfizer/BioNTech and Moderna coronavirus (COVID-19) vaccine doses. The agreement includes access to modified vaccines, should they be needed in response to the new Omicron variant of coronavirus. Under the deal, 60 million doses of the Moderna vaccine and 54 million of the Pfzier/BioNTech doses are due to be supplied to the UK throughout 2022–2023.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial